The counter opened at Rs 722.0 and touched an intraday high and low of Rs 730.3 and Rs 717.35, respectively, in the session so far. Shares of the company of Aurobindo Pharma Ltd. quoted a 52-week high of Rs 1063.75 and a 52-week low of Rs 660.1.
Total market cap of the Aurobindo Pharma Ltd. stood at Rs 42067.46 crore at the time of writing this report.
Key Financials
The company reported consolidated net sales of Rs 5783.29 crore for the quarter ended 30-Jun-2021, down 4.87 per cent from previous quarter’s Rs 6079.6 crore and down 4.26 per cent from the year-ago quarter’s Rs 6040.37 crore.
The net profit for latest quarter stood at Rs 769.97 crore, down 1.36 per cent from the same quarter a year ago.
Shareholding pattern
As of 30-Jun-2021, domestic institutional investors held 9.03 per cent stake in the firm, while foreign institutional investors held 25.65 per cent and the promoters 51.83 per cent.
Valuation ratio
According to BSE data, the stock traded at a price-to-earnings multiple of 7.9 and a price-to-book ratio of 2.36. A higher P/E ratio shows investors are willing to pay a higher price because of better future growth expectations. Price-to-book value indicates the inherent value of a company and is the measure of the price that investors are ready to pay even for no growth in the business.
Aurobindo Pharma Ltd. belongs to the Pharma – Indian industry.
